KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Inventory Average (2016 - 2025)

Historic Inventory Average for Acadia Pharmaceuticals (ACAD) over the last 10 years, with Q3 2025 value amounting to $27.6 million.

  • Acadia Pharmaceuticals' Inventory Average fell 5834.45% to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.6 million, marking a year-over-year decrease of 5834.45%. This contributed to the annual value of $28.9 million for FY2024, which is 3606.88% up from last year.
  • Per Acadia Pharmaceuticals' latest filing, its Inventory Average stood at $27.6 million for Q3 2025, which was down 5834.45% from $24.5 million recorded in Q2 2025.
  • Acadia Pharmaceuticals' 5-year Inventory Average high stood at $66.7 million for Q2 2024, and its period low was $6.1 million during Q3 2022.
  • For the 5-year period, Acadia Pharmaceuticals' Inventory Average averaged around $22.4 million, with its median value being $12.6 million (2021).
  • As far as peak fluctuations go, Acadia Pharmaceuticals' Inventory Average skyrocketed by 77263.63% in 2024, and later plummeted by 6323.12% in 2025.
  • Quarter analysis of 5 years shows Acadia Pharmaceuticals' Inventory Average stood at $11.1 million in 2021, then tumbled by 43.83% to $6.2 million in 2022, then skyrocketed by 353.42% to $28.3 million in 2023, then soared by 46.66% to $41.5 million in 2024, then tumbled by 33.46% to $27.6 million in 2025.
  • Its last three reported values are $27.6 million in Q3 2025, $24.5 million for Q2 2025, and $22.4 million during Q1 2025.